Brief: Aridis Pharmaceuticals Reports Qtrly Net Loss Per Share Of $0.44
16/05/2022 21:07
May 16 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS PHARMACEUTICALS INC - TOTAL CASH, CASH EQUIVALENTS
AND
RESTRICTED CASH AS OF MARCH 31, 2022, WERE APPROXIMATELY $14.2
MILLION
* ARIDIS PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE TO
COMMON
STOCKHOLDERS, BASIC AND DILUTED $0.44
Source text for Eikon: ID:nPn3FB4cFa
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music